Article
AEBP1 as a promising therapeutic target for skeletal muscle insulin resistance in type 2 diabetes mellitus: Convergent evidence from Mendelian randomization and functional validation
4 Jul 2025
Abstract excerpt
No abstract is available from the source.
Topics
Join the communities discussing this publication.